There Is No Association of Radioactive Iodine Treatment with Cancer Mortality in Patients with Hyperthyroidism
- 4 October 2019
- journal article
- editorial
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 60 (11), 1500-1501
- https://doi.org/10.2967/jnumed.119.235929
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-makingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With HyperthyroidismJAMA Internal Medicine, 2019
- A Critical Assessment of the Linear No-Threshold HypothesisClinical Nuclear Medicine, 2019
- Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of WomenThyroid®, 2017
- Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for HyperthyroidismJournal of Clinical Endocrinology & Metabolism, 2015
- Cancer Risk in Patients with Graves' Disease: A Nationwide Cohort StudyThyroid®, 2013
- Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspectiveEndocrine-Related Cancer, 2013
- 131I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignanciesNuklearmedizin-Nuclear Medicine, 2011
- Cancer Mortality Following Treatment for Adult HyperthyroidismPublished by American Medical Association (AMA) ,1998
- Incidence of Leukemia Following Treatment of HyperthyroidismPublished by American Medical Association (AMA) ,1968